EvaluatePharma - Ipsen - Worldwide

EvaluatePharma® - the premier source for pharma and biotech analysis.

Expert integration of financial and product data across historic and forecast timeframes (1986 to 2016) delivers a vast array of analytics by product, company, therapy area, EphMRA ATC code, technology, patent status, deals, license revenues and much more.

Company Profile



Profile	Ipsen is a France based pharmaceutical company, focused on the development and marketing of products for oncology, endocrinology and neuromuscular disorders.
Listed or Private Company	Listed
Company Classification	Regional Major
Company Website	Website

Full Company Profile Information

EventAnalyzer - Last Key Event


Closing Price DateClosing Price Date	EventAnalyzer Note	Market Cap (US $m)	Change (%)	Change (+$m)
8/31/2010	31 Aug: Shares fall despite the company reporting a 7% increase in H1'10 earnings, beating expectations, helped by growing sales of the company's specialty care drugs; company maintains its full-year outlook.	2,770	-3.5%	-100

Top 3 Products (Worldwide Sales 2007/08)

				Annual Sales WW - Sales		Growth per Year (%)
Rank¹	Product	Generic Name	Therapeutic Subcategory	2007	2008	2008
1	Decapeptyl/Pamorelin	triptorelin pamoate	Hormone therapies	322²	364³	+13%
2	Dysport	abobotulinumtoxinA	Muscle relaxant, peripheral	176⁴	209⁵	+19%
3	Somatuline	lanreotide acetate	Pituitary & Hypothalamic hormones	142⁶	177⁷	+25%

Note: Shaded Cells⁸

RX Sales Chart

Ipsen	Data		Growth
	2007	2008	2008
Revenues By Segment
Pharmaceuticals
Pharmaceuticals Sales (In-depth)
Rx & OTC Pharmaceuticals
Prescription (Rx) Pharmaceuticals	1,216	1,376	+13%

Therapy Area Focus in 2008

Ipsen
	2008
WW Rx & OTC Sales By Therapy Area
Main Categories
Blood⁹	0
Cardiovascular¹⁰	114¹¹
Central Nervous System¹²	164¹³
Endocrine¹⁴	236¹⁵
Gastro-Intestinal¹⁶	268¹⁷
Musculoskeletal	223¹⁸
Oncology & Immunomodulators¹⁹	364²⁰
Other Rx & OTC Pharma²¹	7

EvaluatePharma® Coverage of Marketed and Pipeline Products


	Product Count
Ipsen ²²	103

2009 Product Sales analysis
2009 Pharmaceutical Sales
2009 Market Share & Global Ranking
Download to Excel
Search 2 yrs of company press releases


EP Vantage - last 6 months

Therapeutic focus - Avandia's decline and the type 2 diabetes market (July 15, 2010)

Big pharma continues to struggle in first half, Indian generics consolidate gains (July 01, 2010)

ADA - Roche's diabetes dreams fade as taspo data deteriorates (June 29, 2010)

GTx in soul searching mode following toremifene failure (May 26, 2010)

Event - European approval would start cash trickle for GTx (March 11, 2010)

Ranked on:
Annual Sales WW
2008

Group Total: Equals the sum of values in report based on report grouping.

Note: Where Top 5,10,100 etc filters have been applied, the aggregate value relates to the total of the original unfiltered group - not the displayed filtered data. Where n/a appears, a value has been hidden but is included in Group Total.

Examples:

e.g. Top 100 drugs reports. These are not grouped but are filtered to show only the top 100 products by sales in a particular year. The Group Total displayed is equal to the sum of all data within Evaluate Pharma - not just the top 100 products i.e. total market size.

e.g. Global Majors - Top 10 products. Report is grouped by Company and filtered to show only the top 10 products by sales in a particular year. Group Totals are displayed for each company and are equal to the sum of all available data for that company - not just the top 10 products.

XXXXXXX XXXXXXX:

XXXXXX: XX XXXX XXXXXXX (XX XXX XXXX):
XXX XXX XXXX XXXX XXXX, XXXXX XX XXXXXXXXXX® XXXX XX X.X%, XXXXXX XX XXXXXX XXXXX XX XXX XXXXXX XXXX, XXXXXXX, XXXXX, XXX XXXXXXX XXXXXX (XXXXXXXXXXXX XXXXXX) XXXXXXX XXX XXXXXXXX XXXXX XXXXXXX XX XXXXX XXXXXXXXX XXXXX XXX X XXXXXXX XXXX-XXXX XX XXXXX XXX XX XXXXXXX.

XX XXX XXXXXX XXXXXXX XXX XXXXXXXXXX XX XXXXXX XXX XXXXXXXX XXXX XXXXX XXXXXXXXX XX XX X XXXX XXXX XXXX X.X % XX X.X% XXX XXXXXXX®, XXXXXXXXXX® XXX XXXXXXXXXX® XXXXXX XX XXXX-XXXXXXXX XX XXXXXXX XX XXX XXXXXXXXXX XXX XX XXXX-XXXXXX XXXXX XXXXXXXXXXX XX XXXXXXXXXX®.

XXXXXXX XXXXXXX:

XXXXXX: XX XXXX XXXXXXX XXXXXXXXXXXX (XX XXX XXXX):
XXXXXXXXXX®: XXXXX’X XXXXXXX XXXXXXX
X XX XXXXX XXXXXX XXXXX…
XXXXXXXX XX XXXX XX XXXXXXXXX (XX-XX, XXXX. XXXXXX, XXXXX…)
XXXXXXXXXXX:
- XXXXXXXX XXXXXX (XXXX XXXX XX% XX XXXXX)
- XXXXXXXXXXX
- XXXXXXXXXX XXXXXXX
- XXX
XXXXX, X XXXXX XXXXXXXXXXX & X XXXXX XXXXXXXXXXXX
- XXXXXXX XXX XXX XX XXX XXXX
XX XXXXXXXX XX XXXX XXXXXXX XXXXXXXXXXX
- XXXX XXXX-X-XXXXX (X XXXXXXXX XX XXXXXXX)
- XXXX-X-XXXXX XX XXXXXXXXXXX X&X XX XXXXXXXXXXX XXXXX
… XXX XXXXX XXXXXX XX XXXX
X XXXXX XXXXXXXXXXX XXXXX XX XXXXXX
X XXXXXXX XXXXXX:
- XXXXXXX XXXXXXXXXX
- XXXXXXX XXXXXXXXX
XXXX XXXX XX XXXX XX XXXX XXXXXXXX XXXXXXXXX XXXX XXXX XXXXXX XXXXXXXX
XXXX XXXX XX XXXX XX XXXX XXX XXXXXX XXXXXXX XXXXXXX XXXXXX XXXXX XXXX

XXXXXXXXXX® X XXXXXX XXXXXXXXXXX: X XXXXXXXXXXX XXXXXXX XXXXXXX
XXXXXXXXXXX XXX XXXXXXXX
- XXXXXXXX X XXXXX (XX) XXX X XXXXX (XX) XXXXXXXXXXXX
- XXXXXXXXXXX XX XXXXXXXX XXXXXXXXXXXX XXXXXX XX XX XX XX% XX XXXXXXXXX
- XX XX, XX% XXXXXXXX XX XXX XXXXXX, XXXXXXX XXXXXX XXXXXXX
XXXXX XXXXXXXXX/ XXXXXXXXXXX
- XX XXXXX XX XXXXXXXXXXXXXX, XXXX XXXXX XXXXXXXXX
- XXXXXXXXX XXX XXXXXXX XXX XXX XXXXXXX
XXXXXXX XXX XXXXXXXXXXXXXX
- XXXXXX XX XXXX XXXXXXXXXXX
- X XXXXX XXXXXXXXXXXXXX
- XXXXXX XXXXXX XXXXXX
XXXXXXXXXXX XXX XXXXXXXX
XXXXXXXXXX X
?? XXXXXXX XXXXXXXXXXXX XXXXXX XXXXXXXXXXX : XX XXXXXXXXXXX = X,XXXX XX X,XXX XXX XX XXXXXXXXXXX = XX,XXXX XX XX,XXX
?? XXXXXXXXX XXXXXXXX XXXX XX X XXXXXX XX XXXXXXXXXXX XXXXX XX XXXXXXXXXX XX
XXXXXXXXXX X
?? XXXXXXXXXXXX XXXXXXX X - X° = XXXXX XX XX XXXXXX XX XXXXXX XXXXXXXXXXXXXX
?? XXXXXX XXXXXXXXXXXXXX XX XXXXXX XX
?? XXXX XX XXXXXXX, XXXXXXX
XXXXXXXXXX X
?? XXXXX XX XXX XXXXXXX
?? XXXX XXXXX XXXXXX : XXXX XX XXXXX XXXXXXXXXXX

XXXXXXXXXX® X XXXXX XXXXXXXXXXX: X XXXX XXXXXXXXXXXXXX XXXXXXX XXXXXXX
XXXXXXXX
?? XXXXXXXXXX XXXXXXXX XX X XXX X XXXXXX XXXXXXXXXXX
• XXXXXXXXXX XXXXXX (XXXXXXXXXXXX)
• XXXXXXX XXXXXXX (XXX)
XXXXX XXXXXXXXX
-XXXXXXX XXXXX XXXX XXXXXXX (X.X% XX XXXXXXXX )
XXXXXXX XXX XXXXXXXXXXXXXX
-XXXXXXX XX XXXX XXXXXXXXXXX (XX XXXX XX XXXX XX XXXXXX XXXXXXXXXXXXXX)
-X XXXXX XX XXXXXXXXXXXX, XXXXXX XXXXXX, XXX XXXXXX - XX XXXXX
XXXXXXXXXXX/ XXXXXXXX
X XXXXX XXXXXXXXXX X
?? XX% XX XXXXXXXX XXXXXXXXX XXXXX XX X
?? XXXXXXXXXXXX XX XX XXXXXX XXXXX XX* X
?? XXXXXXXXX XX XXXXXXX XX XXXXXXX X
X XXXXX XXXXXXXXXX X
?? XXXX XXXXXXX XXXXXXXXXXX XXXXXXXXX XX XXXXXX XX XXXXXXXX XXXX
?? XXXXXXX XX X-X°: XXXX XX XXXX XX XXX XXXXXXXXXXXXXX X

XXXXXX: XX XXXX XXXXXXX (XX XXX XXXX):
XXX XXX XXXX XXXX XXXX, XXXXX XX XXXXXXXXXX® XXXX XX X.X%, XXXXXXX XXXXXX XX XXXXXX XXXXX XX XXXXX, XXXXXXX, XXXXXXX XXX XXX XXXXXX XXXXXXX, XXXXXXX X XXXXXXX XXXX XXXX XX XXXXXX XX XXX XXXXXX XXXX, XXXXXX XXX XXXXX.

XXXXXXX XXXXXXXXX XXXXXXXXXXX XXXXXXX:

XXXXXX: XXXX XXXXXX XXXXXX, XXXX X:
XXXXXXXXX, XX XXXXXXXX, XXX XXXXXX XXXXXXX XX XXX X-XXXXX XXXXXXXXX-XXXXXXX XXXXXXXXXXX XX XXXXXXXXXX® XX XXXXXX XXX XXX XXXXXXXXX XX XXXXXXX XXXXXXXX XX XXXXXXXXXX XXXXXXX-XXXXXXXXX XXXXXXXX XXXXXX XXXXXXX XX XXXXXXXXX XXXX.

XXXX XX:
XXXXXXX XXXXXXX XX XXXXXXXXXX, XXXXX XX XXXXXXXXXX XX XXX XXXXXXXX XXXXXXXXX XX XXXXXXX XX XXXXXXXX XXXXXX. XX XXXXXXXXX XXXX, XXX XXXXX XXXXX XXX XXXXXXXXX XXXXXXXXXXXXX XX XXXXXX XXX X XXX X-XXXXX XXXXXXXXXXX XX XXXXXXXXXX® XX XXXXXXX XX XXX XXXXXXXX X-XXXXX XXXXXXXXXXX. XX XXXXXX XX XXXXXXXXX XX XXX XXXXXX XX XXX XXXXXX XXXXXX.

XXXX XX:
XXXXX XXXXXXXXXXX XX-XXXXXXXX XXXX XXXXXXXXXX XXX XXXX-XXX XXX XXX XXXXXX XXXXXXXXXXXX XXX XXX XXXXXXXXXXXXXXXXX XXXXXX XX XXXXXXXXXX® (XXXXXXXXXXX XXXXXXX) XX XXX XXXXX XXXXXXXXX XXXXX XXXXXXX, XXX XXXXXXX XXXXX XXXXXXXXX (XXXXXX, XXXXXX, XXXX XXX XXXXX). XX XXXXXXX XXXXXXX XXXXX XX XXXXXX XXXXXX XXXXXXXXX-XXXXXXX XXXXXXXXXXXX XX XXXXXXXXXX® XXXXXXXXX XX XXXXXXXXXX, XXXXX XXXXX X X-XXXXX XXXXXXXXX-XXXXXXX XXXXXXXXXXX XXXXX XXX XXXXX XXX XXXXXXXXX XXXXXXXXXXXXX XX XXXXXX XX XXXX.

XXXXXXX XXXXXXX

XXXXXX: XXXX XXXXXX XXXXXX, XXXX XX:
XXXXXXX®, XXXXX XXXX XX XXXXX XXXXXXXXXXXXX XXXXXXX, XXXXX XXXXXXXX XXXXXXXX XXXXX XXX XXXXXXXXX XXXXXXXXX XXX XXX XXXXXXXXX XX XXXXX XXXXXXXXX XXX XXXXXXX XXXXX XX XXXXXXXX XXXXXXXXXX, XXXXXXXXX XXXXXXXX XXXXXXXX (X XXXXXXX XXXXXXXXX XX XXXXX XXX XXXX XX XXXXXXX XX XXXXXXXX), XXXXXXXXXX XX XXX XXXXX XXXXX (XXXX) XX XXXXXXXX XXXX XXXXXXXX XXXXX, XXXXXXXXXXXXX (XXXXXXXXXXX XXX XXXXXXX) XXX XXXXXXXXXX XXXXX. XX XXX XXXXX XXXXXXXXX XXX XXX XXXXXXXXX XX X XXXX XXXXXXX XX XXXXXXXXXXXXX XXXXXXXXX XXX XXXXXXXXX XXXXXXXX. XX XX XXXXXXXX XXXX, XXXXXXX® XXX XXXXXXXXX XXXXXXXXXXXXXX XX XXXX XX XXXXXXXXX. XX XXXX, XX% XX XXXXXXX® XXXXX XXXXXXX XXXX XXX XXXXX XXXXXXX XXXXXXXX XXXXXXXXX.

XXXXXX: XX XXXX XXXXXXX (XX XXX XXXX):
XXX XXX XXXX XXXX XXXX, XXXXX XX XXXXXXX® XXXXXXXX XX €XXX.X XXXXXXX, XX XX.X% XXXX-XX-XXXX XXXXXX XX XXXXXX XXXXXX XX XXX XXXXXX XXXXXXX, XXXXXX, XXXXXX, XXXXXXX XXX XXXXXX.

XX XXX XXXXXX XXXXXXX XXX XXXXXXXXXX XX XXXXXX XXX XXXXXXXX XXXX XXXXX XXXXXXXXX XX XX X XXXX XXXX XXXX X.X % XX X.X% XXX XXXXXXX®, XXXXXXXXXX® XXX XXXXXXXXXX® XXXXXX XX XXXX-XXXXXXXX XX XXXXXXX XX XXX XXXXXXXXXX XXX XX XXXX-XXXXXX XXXXX XXXXXXXXXXX XX XXXXXXXXXX®.

XXXXXXX XXXXXXX:

XXXXXX: XX XXXX XXXXXXX XXXXXXXXXXXX (XX XXX XXXX):
XXXXXXX®: XXXXXX XXXXX, XXXXXX XXXXXXXXX XXXX XXXXXX
- ~XX% XXXXX XXXX XX-XX XXXX- XX XXXX
XXXX XXXXXXX XXXXXXXX
- XXX,XXX XXXXXXX/ XXXX
XXXXX XXXXXXXXXX XXXXXX XX XXX XX
- XX XXXXXXXXXX XXXXXXXX XXXX XXXXXXXXX
XXXXX-XX-XXX XXX XXXXXXXXXXXXX
- XXXX XXXXXXXXX XXXX XXX
XXXXX XXXXXX XXX. XX XXXXXXX XXXXX XX XXXXXXX XXXX XXX XXXXXXX® XXXXXXXXXXX
X XXXXXX XXXXXXXXXX XXXX XXXX XXXX XXXXXXXX XXX XXXXXX® XXXXXXX XXX XXXXXXXX
-XX XXXXX XXXXXXXXXXXXXXX, XXXXXXXXXXX XX XXXXXXXXX XX XXXXXXXXXX XXXXXXX
-XXXXXXXXXXX XXXXXXXXXXXXX XXXX XXX XXXXXXXXX XXXXXXX XXXXXXX
-XXXXXXX XX XXXXXXXX XXXXXXXX XXXXXX XXXXXXX XXXXXXXX
• XXXXXXXX XXXX XXXXX XXXXXX ~XX% XX XXXXXXXX XXXXXXXX XXXXXXXXXX
• XXXXXXXXXX XXXXXXXX XX XXX XXXXXXXX XXXXXXXX & XXXXX XXXXXXXXXX XXXXX XXXXXXXXXXX XXXXX XXX XXXXXXXXX XXXXX
XXXXXXXXXXX XXXXXXX XXXX XXXX
-XXXXXX XXXXXXXXXXX XXXXX, XXXXXXXXXXX XX XXXXXXXXXX XXXXXXXX
-XXXXXXXX XXXXXXXXX XX XXXXXXXX, XXXXXX XXX XXXXXXXXXXXXX XXXXXXXXXX
-XXXXXXXX XXXXXXXXXXX XXXXXXXXXXXXX XXXX XXX XXXXXX XX XXXXXXXXXXXXX XXXXXXXXX
XXXX XXXXXXXXXX XX XXXXX XXX XXXXXX XXXXXXXXX XXXXXXXXXX

XXXXXX: XX XXXX XXXXXXX (XX XXX XXXX):
XXX XXX XXXX XXXX XXXX, XXXXX XX XXXXXXX® XXXXXXXX XX €XXX.X XXXXXXX, XX XX.X% XXXX-XX-XXXX (XX XX.X% XXXXXXXXX XXXXXXX XXXXXXXX XXXXXXX), XXXXXXX XX XXX XXXX XXXXXXXXXXXX XX XXXXXX, XXXXXXX, XXXXXX, XXXXX XXXXXXXX XXX XXXXXX XXX XX XXX XXXXX XX XXX XXXXXXXXXXXX XXXXXXXXX XX XXXXXXXXX XXXXXXXXXXX XXXX XXXXXXXX XX XXXXXX.

XXXXXXX XXXXXXXXX XXXXXXXXXXX XXXXXXX:

XXXXXX: XXXX XXXXXX XXXXXX, XXXX X:
XX XXXXXXXXX, XX XX XXXXX XXXX, XXX XXX XXXXXXX XXXXXXXXX XXXXXXXXXXXXX XXX XXXXXXX™, XXX XXXXXXXXX XXXXX XXXX X XXX XXX XXXXXXXXX XX XXXXXXXX XXXXXXXX XXX XXXX XXX XXXXXXXXX XXXXXXXX.

XX XXXXXXXX XXXX, XXX XXXXXXXXX XXXXX XXXXXXXX® XXXXXXXX XXX XXXXXXXXXX XXXXX XXXXX XXXX XX XXXXXXXX XXXXXXXXX’ XXXXXX XXXXXXXXXXX XXX XXX XXXXXXXX XX XXXXXXXX XXXXXXXXX XXXXXXXXXXXXXX, XX XXXXXXXXX XXX XXX XXX XXXXXXXXX XX XXXXX XXXXX. XXXXXXXX XXXXXXXXX XXXXXXXXXXXXXX XXX XXXXXXXX® XXXX XXXXXXX XXXX XXXXXXX XX XXX XXXXXX XXXXXXX, XXXXXXX, XXXXXXXX XXX XXXXXX.

Company Specific NameHaematology

XXXXXXX XXXXXXX:

XXXXXX: XXXX XXXXXX XXXXXX, XXXX XX:
XXXXXXXXXX® XXX XXXXXXXXXX® XXXXXXX® XXX XXXXXXXXX-XXXXXXX XXXXXXXXXXXX XXX XXXXXXXXX XXXXXXXXXX XXXXXXXXXX, X XXXXXXXXXXXX XXXXXXXX (X XXXXXXX XXXX XXXXXXXX XXX XXXXXXX XX XXXXXX XXXXXXX).

XXXXXXXXXX® XX XXXX XXXXXX XX XXX XXXXXXXXX XX XXXXXXXXXX (X XXXXXXXX XXXXXX XX XXX XXXX-XXXXXXXXXX XX XXXXXX XXXXXXX XXX XX X XXXXXX XXXXXX XX XXX XXXXXXXX XXXXXXXXX XXXXX). XXXX XXXXXXX XXXXXXXXXXXX XXXXXXXXX XXXXXXX XXXXXXXXXXX XX XXX XXXXXXXXX XX XXXXXXXX XXXXXXXXXX XXXX XXXXXXXXXXXXXX XXXXXXX (XXXXXXXXXXXX XX X XXXXXXXXX XXXX).

XXX XXXXX XXXXXXXX XXXX XXX XXXXXXXXXX® XXXXXXX® XXXXXXXXXXX, XX XXXXX XX XXXXX XXX XXXXXX, XXXXXXXXXX X XXXXX XXXXXXXXXXXXX XXXXXXX. XX XXX XX XXX XXXXX XX XXXXX, XXXX XXXXXXXXXX XXX XXXXX XXXX-XXXXX XXXXXXXXXXX XXX XXXXXXXXX XXXXXXX XXX XXXXXXXXX, XXXXX XXX XXXXXX XXXXXXXXX XXXXXX XXXXXXXX XXX XXXXXXXXX XXXXXXX.

XXXXXXXXXX® XXXXXXX® XXXXXXXX XXX XXXXXX XXXXXXXXX XXXX XX XXXXXXXXX XXXXX XXXX XXXXX XXXX X XXXXXX XX XX XXXXX XX XXXX, XXXX XXXXXXXXX XXXX XXX XXXXXXXXX XXX XXXXX XXXXXXXX XXXX XXX XXX XX XXXXX XXXXXXXXXX XXXXXXXXXX XXXXXXXXX. XXXX XXXXXXX XX XXXXXXXXX XX X XXX-XXXXXX XXXXXXX XXX XXXXXX XXXXXXXXXXXXXX.

XXXXXXXXXX® XXX XXXXXXXXX XXXXXXXX XX XXXXXX XX XXXX. XX XX XXXXXXXX XXXX, XXXXXXXXXX® XXX XXXXXXXXXX® XXXXXXX® XXXX XXXXXXXX XX XXXXXX XX XXXXXXXXX XXX XXXX XXXXXXXX XX XXXX XXXX XX XXXXXXXXX (XXXXXXXXX XX XX XXXXXX) XXX XXX XXXXXXXXX XX XXXXXXXXXX XXX XXXXXXXXXXXXXX XXXXXXX XXX XX XXXX XXXX XX XXXXXXXXX XXX XXX XXXXXXXXX XX XXXXXXXXXX XXXXX. XX XX XXXXXX XXXX, XXX XXX XXXXXXXX XXXXXXXXXX® XXXXX (XXXXXXXXXX) XXXXXXXXX XX, XX XXX XXX XX XX XXX XXXXXX XXXXXX XXX XXX XXXXXXXXX XX XXXXXXXXXX. XXXX XXXX XX XXX XXXXXXXX XX XXXXX XXXXXXX.

XX XXXX, XX.X% XX XXX XXXXX XXXXXXXXX XX XXXXXXXXXX® XXX XXXXXXXXXX® XXXXXXX® XXXXXXX XXXX XXX XXXXX XXXXXXX XXXXXXXX XXXXXXXXX. XXXXXXXXXX® XXXXXXX® XXXXXXXXX XXX XX.X% XX XXXXX XXXXX XX XXXX XXXXXXX XX. XX.X% X XXXX XXXXXX.

XXXXXX: XX XXXX XXXXXXX (XX XXX XXXX):
XXX XXX XXXX XXXX XXXX, XXXXXXXXXX® XXXXX XXXXXXXX XX €XXX.X XXXXXXX, XX XX.X% XXXX-XX-XXXX, XXXXXX XX XXXXXX XXXXXX XX XXX XXXXXX XXXXXXX, XXXXXX, XXXXX, XXXXXXX XXX XXXXXXXXX.

XX XXX XXXXXX XXXXXXX XXX XXXXXXXXXX XX XXXXXX XXX XXXXXXXX XXXX XXXXX XXXXXXXXX XX XX X XXXX XXXX XXXX X.X % XX X.X% XXX XXXXXXX®, XXXXXXXXXX® XXX XXXXXXXXXX® XXXXXX XX XXXX-XXXXXXXX XX XXXXXXX XX XXX XXXXXXXXXX XXX XX XXXX-XXXXXX XXXXX XXXXXXXXXXX XX XXXXXXXXXX®.

XXXXXXX XXXXXXX:

XXXXXX: XX XXXX XXXXXXX (XX XXX XXXX):
XXX XXX XXXX XXXX XXXX, XXXXXXXXXX® XXXXX XXXXXXXX XX €XXX.X XXXXXXX, XX XX.X% XXXX-XX-XXXX (XX XX XX.X% XXXXXXXXX XXXXXXX XXXXXXXX XXXXXXX), XXXXXXX XX XXXXXX XXXXXX XX XXXXX, XXXXXXX, XXXXXX XXXXXXXXX, XXXXXX XXX XXXXX XXX XX XXX XXXXXXXXXX XXXXXX XX XXXXXXXXXX® XXXXX XX XXX XXXXXX XXXXXX, XX XXX XXXXX XXXXXX XXX XXXXX XX XXX XXXXXXX XX XXXXXXX XXX. XXX XX-XXXXXX XXXXX XXXX XXX XXXXXXX XX XXX XXXXXXXXXXX XXX XXXX XXXXXXXXX XXX X XXXXX XXXXXX XX €X.X XXXXXXX.

XXXXXXX XXXXXXXXX XXXXXXXXXXX XXXXXXX:

XXXXXX: XXXX XXXXXX XXXXXX, XXXX XX:
XX XX XXXXXXXX XXXX, XXXXXXXXXX® XXX XXXXXXXXXX® XXXXXXX® XXXX XXXXXXXXXX XX XXXXXX XX XXXXXXXXX XXX XXXX XXXXXXXX XX XXXX XXXX XX XXXXXXXXX (XXXXXXXXX XX XX XXXXXX) XXX XXX XXXXXXXXX XX XXXXXXXXXX XXX XXXXXXXXXXXXXX XXXXXXX XXX XX XX XXXXXXXXX XXX XXX XXXXXXXXX XX XXXXXXXXXX XXXXX. XXXXXXXXXXX, XX XX XXXXXX XXXX XXX XXX XXXXXXXX XXXXXXXXXX® XXXXX XXXXXXXXX XX, XX XXX XXX XX XX XXX XXXXXX XXXXXX XXX XXX XXXXXXXXX XX XXXXXXXXXX. XX XXXX, XX.X% XX XXXXXXXXXX® XXX XXXXXXXXXX® XXXXXXX® XXXXX XXXX XXXXXXXXX XX XXX XXXXX XXXXXXX XXXXXXXX XXXXXXXXX.

XXXX XX:
XXXX XXXXXX XX XXXXXXXX XXX XXXX-XXXXX XX XXXXXXXXXX® XXXXXXX®, XXX XXXXX XX XXXXXXXX XXX XXXXXXXXX XXXXXXXXXXXX: – X XXXXX XXX XXXXXXXX XXXXX XX XXXXXXXXXX® XXXXXXX® XX XXXXX XXXXXXXXX XX XXXXXX XX XXX XXXXXXXXX XX XXXXXXXXXXXX XXXXXXXXXXXXXX XXXXXXX XXX X XXXXX XXX XXXXX XX XXXXXXXXX XXXXX XXX XXXX XXXXXXXXXX® XXXXX XX XXX XXXXXX XXXXXX XX XXX XXXXXXXXX XX XXXXXXXXXXX XXXXXXXXXXXXXX XXXXXXX; – X XXXXX XXX XXXXXXXX XXXXX XX XXXXXXXXXX® XXXXXXX® XX XX-XXXXXXXXXXXXXX XXXX XXXXXXXXXXX XX XXX XXXXXXXXX XX XXXXXXXXXX XX XXXXX XXXXXXXXX XX XXXXXX; – XX XXXXX, XXX XXXXX’X XXXXXXX XXXXXX XX XXXXXXXXX XXXXXXXXXX X XXXXX XX XXXXXXXX XXXXX XX XXXXXXXXXX® XXXXXXX® XXX XXX XXXXXXXXX XX XXXXXXXXXX; – XXX XXXXX XXXXXXXXX XXXXXXXX XXXXXXXXXX XXXXXXXXX XXXXXXXXXXXXXX XXX XXXXXXXXXX® XXXXXXX® XXXXXXX, XX XXXXXX XXX XXXXXX XXX XXX XXXXXXXXX XX XXXXXXXXXX XXX XXXXXXXXXXXXXX XXXXXX.

Company Specific NameCardiovascular

XXXXXXXX XX €X:
X) +XX.XXX XXXXXXXXXXXXXX.

Shaded Cells

A shaded cell signifies potentially incomplete data. E.g. A shaded cell in "Change (+/-)" means there is no corresponding value, i.e. there is data for 2001, but no data for 2000. This could signify a product launch, first time disclosure of sales, a product acquisition or missing data.

A shaded cell containing n/a signifies valid data followed by blank or zero values. E.g. A shaded cell containing n/a in "Change (+/-)" means a value is present for 2000, but blank for 2001. This could signify a product disposal / withdrawal, discontinuation of disclosure or missing data.

Company Specific NameNeurology

XXXXXXXX XX €X:
X) +XXX.XXX XXXXXXXXX XXXXXXXXX.
X) +X.XXX XXXXXX (XXXXXXXXXX XX XXXXX XX XXXXXXXXXXXXXXX, XXXXXXXXXX XX XXXXXXXXXXXXXX XX XXX).

Company Specific NameEndocrinology

XXXXXXXX XX $X:
X) +XXX.XXX XXXXXXXXXXXXX.

Company Specific NameGastroenterology

XXXXXXXX XX $X:
X) +XXX.XXX XXXXXXXXXXXXXXXX.

XXXXXXXX XX €X:
X) +XXX.XXX XXXXXXXXXXXXX XXXXXXXXX.
X) +X.XXX XXXXXXXXX (XXXXXXXXXX XX XXXXX XX XXXXX XXXXXXX XXXX XXXXXXXX, XXXXXXXXXX XX XXXXXXXXXXXXXX XX XXXXXXXXXXXXXXX).
X) -X.XXX XXXXXX (XXXXXXXXXX XX XXXXX XX XXXXXXXXXXXXXXX, XXXXXXXXXX XX XXXXXXXXXXXXXX XX XXX).

Company Specific NameOncology

XXXXXXXX XX €X:
X) +XXX.XXX XXXXXXXX.

Company Specific NameOthers